Our Work

Real Results: How We're Making a Difference Globally

Demonstrable Impact, Measurable Change

At GHMIGROUP, our commitment extends beyond solutions to tangible outcomes. We pride ourselves on creating measurable change for our partners and the communities they serve. Explore our success stories and see the GHMIGROUP difference.

[dflip id="4549"][/dflip]

Ecosageai

https://ecosageai.com/

WellQuest Health APP

https://apps.apple.com/cr/app/wellquest-health/id6554007327

The book by Adebowale Awosika-Olumo is titled “Health Policy: Revolutionizing Wellness: Navigating the Future of Health Policy for Radical Change”. It focuses on the healthcare challenges in sub-Saharan Africa and proposes innovative solutions.

The book delves into various aspects of healthcare, including:

Current state of healthcare systems in sub-Saharan Africa:It examines the challenges and the need for reform.
Healthcare financing models:It explores different approaches like global budgeting, micro-budget allocation, and the roles of free markets and government intervention.
Importance of preventative care and public health:It emphasizes the need for initiatives focused on preventing disease and promoting overall well-being.
Integration of clinical care with universal health insurance:It discusses the importance of ensuring access to healthcare services for all citizens.
Innovative approaches:It explores the potential of technologies like mRNA and telehealth.
Interconnectedness of healthcare with other sectors:It highlights the links between healthcare, education, and agricultural policies.
Case studies of successful health policy reforms:It provides examples from different countries in sub-Saharan Africa.

Leveraging international partnerships and donor funding: It discusses the role of external support in strengthening healthcare systems.

Book

Cases and Testimonials

IsoPSA Test Better Than PSA Test at Detecting Prostate Cancer, Clinical Trial Shows

Cleveland Diagnostics‘ IsoPSA prostate cancer test is significantly better than a standard PSA test at identifying those with prostate cancer and those at risk of developing an aggressive form of the disease, according to the interim clinical trial results.

Long-Term Data Validates IsoPSA for Prostate Cancer Risk Stratification

The IsoPSA prostate cancer test has shown to reliably maintain risk stratification over 30 months, with low-risk patients with prostate cancer remaining stable. This reinforces its value in both early detection and active surveillance strategies.¹

Improve risk assessment to better inform your prostate biopsy decision‑making.

A blood test that more accurately detects high‑grade prostate cancer. Stratify Risk to Improve Patient Management. Confidently avoid biopsy or extend biopsy intervals for lower-risk patients. Identify patients at high risk who need intervention or closer monitoring.

Low Baseline IsoPSA Index is Associated With a Prolonged Low Risk of Clinically Significant Prostate Cancer Diagnosis in Men With an Elevated PSA

To compare the rate of diagnosing clinically significant prostate cancer (csPCa) in men with elevated prostate-specific antigen (PSA) stratified by baseline IsoPSA Index, thus assessing IsoPSA’s intermediate-term predictive ability for csPCa.

Prostate Cancer Detection with IsoPSA®

CPT codes, descriptions, and other data only are copyright 2024 American Medical Association. All Rights Reserved. Applicable FARS/HHSARS apply. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use.

IsoClear™ determines a protein’s origin based on its structure to determine if a patient has cancer

Our proprietary IsoClear platform is tunable to detect underlying cancer biology by measuring changes in the structure of proteins. Adding information on the origin of a biomarker to the current measurement of concentration can add accuracy, specificity, and clarity to cancer diagnostics.

Empowered

nonprofits to improve

financial forecasting

Total Awards